Related by context. All words. (Click for frequent words.) 76 Cardiovascular Events 76 Venous Thromboembolism 76 Patients Receiving 75 Patients Undergoing 74 Anthracycline 74 Invasive Breast Cancer 74 Cardiovascular Outcomes 74 Knee Osteoarthritis 74 Improves Outcomes 74 Meta Analysis 73 Improves Survival 73 Slow Progression 73 Septic Shock 73 Serious Infections 73 Metastatic Prostate Cancer 73 Ischemic Stroke 73 Lowers Risk 73 Appears Safe 73 Fracture Risk 73 Proves Effective 73 Advanced Melanoma 73 Non Alcoholic Fatty 73 Prophylactic Treatment 73 Ischemic 73 Suicidality 73 Hypercholesterolemia 73 Colorectal Adenomas 73 Nonalcoholic Fatty Liver Disease 73 Breast Cancer Recurrence 73 Pooled Analysis 72 Renal Artery 72 Cognitive Decline 72 HER2 Positive 72 Treating Chronic 72 Long Term Efficacy 72 Renal Cell Carcinoma 72 Postmenopausal Women 72 Heart Failure Patients 72 Postmenopausal 72 Aggressive Reduction 72 Thromboembolic 72 Adjuvant Chemotherapy 72 Malignant Melanoma 72 Iron Deficiency 72 Thrombotic 72 Unstable Angina 72 Endometrial Cancer 72 Prolongs Survival 72 Overactive Bladder 72 Progressive Multifocal Leukoencephalopathy 72 Cognitive Impairment 72 Shows Promise Against 72 Liver Failure 72 Gastric Cancer 72 Combination Treatment 72 Fondaparinux 72 Clinical Outcome 72 Hypertensive Patients 72 Asymptomatic 72 Hormone Receptor Positive 71 Inflammatory Markers 71 Unfractionated Heparin 71 Relapsing Remitting Multiple Sclerosis 71 Successfully Treated 71 ACE Inhibitors 71 Carotid Stenting 71 Exacerbation 71 Hypotension 71 Elderly Patients 71 Chronic Hepatitis B 71 Relapsing Multiple Sclerosis 71 Intracerebral Hemorrhage 71 Liver Injury 71 Improve Survival 71 Neoplasms 71 Allogeneic 71 Patients Treated With 71 Increases Risk 71 Levels Linked 71 Preterm Delivery 71 Hepatocellular Carcinoma 71 Atopic Dermatitis 71 Severe Sepsis 71 Drug Prevents 71 Drug Shows Promise 71 Pediatric Patients 71 Chemoradiation 71 Reduces Mortality 71 Controlled Trial 71 Acute Pancreatitis 71 Prostatic 71 Pregnancy Linked 71 Randomized Controlled Trial 71 Is Well Tolerated 71 Rheumatoid Arthritis Patients 71 Premature Infants 71 Blood Clots 70 Obesity Linked 70 Surgical Treatment 70 Antitumor Activity 70 Myocardial Ischemia 70 Test Detects 70 Subgroup Analysis 70 complement inhibitor eculizumab 70 leiomyomas 70 Leukemias 70 Severe Asthma 70 Invasive Fungal Infections 70 Hormone Refractory Prostate Cancer 70 Metastases 70 Bone Metastases 70 Disease Progression 70 Neuroprotective Effects 70 Fungal Infections 70 Newly Diagnosed Multiple Myeloma 70 Adjuvant Treatment 70 Predict Risk 70 Node Positive 70 Increased Mortality 70 Demonstrates Efficacy 70 Oral Fingolimod 70 Systematic Review 70 Breast Cancers 70 Localized Prostate Cancer 70 Atypical Hemolytic Uremic Syndrome 70 Cholesterol Levels SPARCL 70 Microalbuminuria 70 Inhaled Corticosteroids 70 Tumor Growth 70 Shows Promising 70 Cholesterol Lowering Drug 70 Catheter Associated 70 Kidney Function 70 Peripheral Arterial 70 Non Alcoholic Steatohepatitis 70 Lung Cancer Patients 70 Antiplatelet 70 Skin Lesions 70 Squamous Cell 70 Reduces Risk 70 Heterozygous Familial Hypercholesterolemia 70 Chronic Renal Failure 70 Chronic Lung 70 Statin Therapy 69 Chronic Sinusitis 69 Malignant Glioma 69 Adjunctive Therapy 69 Therapy Shows Promise 69 Acute Renal Failure 69 Gene Mutation 69 Peptic Ulcer 69 Endothelial Function 69 Recurrent Breast Cancer 69 Previously Treated 69 Treatment Shows Promise 69 Secondary Hyperparathyroidism 69 Recurrent Stroke 69 Hospital Acquired Pneumonia 69 Hyperkalemia 69 Bone Fractures 69 Patency 69 Genes Linked 69 Chronic Bronchitis 69 Risk Stratification 69 Juvenile Idiopathic Arthritis 69 Lung Injury 69 Viral Infections 69 Basal Cell 69 Investigational Treatment 69 Malignancies 69 Transdermal Patch 69 Nebulized 69 Adjuvant Therapy 69 Insulin Resistance 69 Therapeutic Effects 69 Kidney Failure 69 Iron Overload 69 Skeletal Muscle 69 Diabetic Patients 69 Randomized Study 69 dual endothelin receptor antagonist 69 Hepatotoxicity 69 Antipsychotic Medications 69 Effective Treatments 69 Chronic Heart Failure 69 See CLINICAL PHARMACOLOGY 69 Statistically Significant 69 Respiratory Tract Infections 69 Thiazolidinediones 69 Autoimmune Disease 69 Immune Responses 69 Acute Ischemic Stroke 69 Bronchopulmonary Dysplasia 69 Effectively Treats 69 Statin Drugs 69 Treatment Reduces 69 Insulin Sensitivity 69 Restenosis 69 Dual Antiplatelet Therapy 69 Subtypes 69 Sleep Disturbances 69 Hyperlipidemia 69 Complicated Skin 69 Acute Liver Failure 69 Gene Mutations 69 Nonalcoholic Steatohepatitis 69 Cognitive Function 69 Benign Prostatic Hyperplasia 69 Premenopausal Women 69 Occlusive Disease 69 Breast Cancer Treatment 69 Shows Efficacy 69 Prospective Randomized 69 Insulin Glargine 69 Single Dose 69 Breast Cancer Metastasis 69 TNF Blockers 69 Osteoporosis Drugs 69 Refractory Hodgkin Lymphoma 69 Genes Predict 69 Anticoagulant 69 Irritable Bowel 68 Autologous Stem Cell Transplantation 68 Mouse Model 68 Ovarian Cancer Patients 68 Stomach Cancer 68 Reduced Risk 68 Primary Hypercholesterolemia 68 Acute Myocardial Infarction 68 Myelodysplastic Syndromes 68 Improved Survival 68 Myelodysplastic Syndrome MDS 68 Relapsed Refractory 68 Rotavirus Vaccine 68 Well Tolerated 68 HER2 Positive Breast Cancer 68 Urinary Tract Infections 68 Renal Impairment 68 Therapy Reduces 68 Atherosclerotic 68 deep venous thromboses 68 Potentially Fatal 68 Acute Coronary Syndromes 68 endometrial hyperplasia 68 Left Ventricular 68 Endocarditis 68 recurrent venous thromboembolism 68 Radical Prostatectomy 68 Polycystic Ovary Syndrome 68 Hemodialysis Patients 68 Allergic Asthma 68 Multicenter Study 68 Chemotherapeutic Agents 68 Resistant Hypertension 68 Improve Outcomes 68 Slows Progression 68 Beneficial Effects 68 Adenomas 68 Chronic Myeloid Leukemia 68 Smoking Linked 68 Novel Treatments 68 Advanced Prostate Cancer 68 Monotherapy 68 Gene Linked 68 Survival Benefit 68 Renal Insufficiency 68 Virus Infection 68 Antidepressant Use 68 Uterine Cancer 68 Diabetic Nephropathy 68 Chronic Pelvic Pain 68 Angioedema 68 Cardiac Resynchronization 68 Soft Tissue Sarcoma 68 Beta Blockers 68 Ascites 68 Symptom Relief 68 Allergic Rhinitis 68 Protein Linked 68 Radiofrequency Ablation 68 Hemolysis 68 Replacement Therapy 68 Dendritic Cells 68 Postmenopausal Osteoporosis 68 Carcinomas 68 Idiopathic 68 Glatiramer Acetate 68 Poorly Controlled 68 Nicotine Vaccine 68 Bone Mineral Density 68 Previously Untreated 68 Colorectal Cancers 68 CLINICAL STUDIES 68 Obese Patients 68 Cholesterol Levels 68 Breast Cancer Patients 68 Newly Diagnosed 68 Polyneuropathy 68 Sustained Efficacy 68 Sipuleucel T 68 Stress Incontinence 68 Artery Disease 68 Proteinuria 68 Bacteremia 68 Esophageal Cancer 68 metastatic malignant 68 Experimental Vaccine 68 Meets Primary Endpoint 68 Chemotherapy Induced 68 NIDDM 68 Liver Damage 68 Adjunctive 68 Drug Combo 68 Aggressive Prostate Cancer 68 Naive Patients 68 Randomized Controlled Trials 68 Genetic Markers 68 Preclinical Study 68 Prevent Heart 68 Hepatitis C Virus 68 Platelet Inhibition 67 Fibroblast 67 Critically Ill Patients 67 Diabetic Neuropathy 67 Prospective Randomized Trial 67 Aortic Stenosis 67 Vaginal Gel 67 Bivalirudin 67 Helicobacter Pylori 67 Intracerebral 67 Infected Patients 67 Combo Therapy 67 Coronary Arteries 67 Cancer Recurrence 67 Diabetic Foot Ulcer 67 Beta Blocker 67 Demonstrates Sustained 67 Pulmonary Arterial Hypertension 67 Infarct 67 Unresectable 67 Periodontal Disease 67 Physician Insights 67 Phase 2b Clinical Trial 67 Genetic Marker 67 Chronic Constipation 67 Myelofibrosis 67 Cell Transplants 67 Bloodstream Infections 67 Treatment Naive Patients 67 Phase IIa Clinical Trial 67 Combination Therapy 67 Stable Coronary Artery 67 Postherpetic Neuralgia 67 Nesiritide 67 Brain Shrinkage 67 Guidelines Issued 67 Vertebral Fractures 67 Neoadjuvant Chemotherapy 67 Dyslipidemia 67 Cardiotoxicity 67 Hormone Therapy 67 Diabetes Hypertension 67 Venous Thrombosis 67 Fixed Dose 67 Colorectal Cancer Risk 67 Atorvastatin Evaluation 67 Insulin Therapy 67 Tiotropium 67 Chronic Hepatitis C 67 Brain Atrophy 67 Renal Cancer 67 J Am Coll 67 Achieves Primary Endpoint 67 #-# Full Text 67 abacavir Ziagen 67 Hydroxyurea 67 Bladder Cancer 67 Antiviral Therapy 67 Chronic Liver Disease 67 Hypertrophy 67 Patients Suffering 67 Migraine Headaches 67 Randomized Double blind 67 Unstable angina 67 Fluorouracil 67 Mortality Risk 67 Interferon Beta 67 Adenoma Prevention 67 Investigational Compound 67 Gene Variation 67 Minimally Invasive Treatment 67 Progenitor Cells 67 Cervical Dysplasia 67 Breast Cancer Cells 67 Non Responders 67 Malformations 67 Often Misdiagnosed 67 Analytical Tool 67 Anticoagulants 67 Amniotic Fluid 67 See WARNINGS 67 Gastrointestinal Disorders 67 Oral Mucositis 67 Controlled Study 67 Antihypertensive 67 Patients Treated 67 Reperfusion Injury 67 Coronary Disease 67 Coronary Angiography 67 Paroxysmal Nocturnal Hemoglobinuria PNH 67 Brain Tumors 67 Myeloma Patients 67 Lung Cancer Survival 67 STRIDE PD 67 Novel Oral 67 Prophylaxis 67 Valvular 67 Orthostatic Hypotension 67 Increased Risk 67 Gum Disease 67 Advanced Ovarian Cancer 67 Preclinical Models 67 Paroxysmal Nocturnal Hemoglobinuria 67 Kidney Transplant Recipients 67 Lupus Nephritis 67 Virus Linked 67 Neoadjuvant 67 Squamous 67 Risedronate 67 Nymox NX 67 Short Stature 67 Clostridium difficile Infection 67 Metastatic Colorectal Cancer 67 variceal bleeding 67 Coronary Artery Bypass Graft 67 Arrhythmias 67 Adenoma 67 Dasatinib 67 Idiopathic Pulmonary Fibrosis 67 Prevent Breast Cancer 67 Breast Density 67 Immunosuppression 67 Prognostic Value 67 Recombinant Human 67 Significantly Reduced 67 Taxane 67 Patient Outcomes 67 Endocrine Therapy 67 Nilotinib 67 Mitral Regurgitation 67 Respiratory Distress 66 Randomized Double Blind 66 Hemoglobin Levels 66 Functional Outcomes 66 Higher Doses 66 Cancer Incidence Mortality 66 Coronary Artery Calcium 66 Aliskiren 66 invasive aspergillosis 66 Respiratory Infections 66 Menopausal Symptoms 66 Hypoglycaemia 66 Proven Effective 66 Glucocorticoid 66 Fibrinogen 66 Acute Coronary 66 Depressive Symptoms 66 Hemorrhagic 66 Contrast Agents 66 Azacitidine 66 Growth Hormone Deficiency 66 Endometrial 66 Endothelial 66 Oral Contraceptives 66 Neonates 66 Help Predict 66 C Reactive Protein 66 Viral Suppression 66 Robotic Assisted 66 Androgen Deprivation Therapy 66 cytomegalovirus infection 66 Epilepsy Drug 66 Acute Myocardial 66 Urinary Incontinence 66 Placebo Controlled Study 66 Boosts Survival 66 Pharmacokinetic Study 66 Commonly Used 66 Organ Rejection 66 Albuminuria 66 Treatable 66 Blood Pressure Drugs 66 Novel Mechanism 66 ST Segment Elevation 66 Prostate Cancer Risk 66 Breast Tumors 66 colorectal adenoma 66 Bazedoxifene 66 invasive candidiasis 66 Hip Fractures 66 Shown Effective 66 Demonstrates Positive 66 Cyclooxygenase 2 66 Aortic Valve 66 Chronic Prostatitis 66 Inhaled Nitric Oxide 66 Non Invasive Treatment 66 AVAPRO 66 Genes Identified 66 Lung Function 66 Malignancy 66 Diastolic Heart Failure 66 Prospective Cohort Study 66 Pulmonary Artery 66 Breast Cancer Risk 66 Infarction 66 Uterine Fibroids 66 FDA Approvals 66 Left Ventricular Hypertrophy 66 Viral Load 66 Lymphocytic 66 Left Ventricular Dysfunction 66 Low Doses 66 Enoxaparin 66 Study Evaluating 66 Osteoporotic 66 Enlarged Prostate 66 Genital Herpes 66 Precancerous 66 Adverse Effects 66 Tyrosine Kinase Inhibitor 66 Thyroid Hormone 66 Hip Fracture 66 Medication Errors 66 Bone Fracture 66 Duodenal 66 Prostate Cancer Patients 66 Peginterferon 66 Phase III Clinical Trial 66 Stent Implantation 66 Antibiotic Use 66 Bowel Disease 66 Transplant Rejection 66 Phase 2b Trial 66 Gestational Diabetes 66 Arteriosclerosis 66 Randomized Trials 66 Postmarketing 66 Comorbidities 66 Papillary 66 Ischaemic 66 ST Elevation Myocardial 66 Multidrug 66 Embolism 66 Genes Associated 66 Trial Evaluating 66 Small Intestine 66 BARACLUDE ® 66 ergot derivatives 66 Pneumococcal Vaccine 66 Cell Lymphoma 66 Who Underwent 66 PHPT 66 Drug Resistant 66 Sleep Disordered Breathing 66 Lung Transplants 66 Cognitive Problems 66 Prostate Cancers 66 Skin Cancers 66 Therapy Improves 66 Pegylated Interferon 66 Myocardial Infarction 66 Uric Acid 66 Gastroesophageal Reflux Disease 66 Complication Rates 66 CT Angiography 66 Metastatic Melanoma 66 HeFH 66 Significantly Reduces 66 Vitamin D Deficiency 66 Successfully Treats 66 Squamous Cell Carcinoma 66 Female Stress Urinary 66 Respiratory Syncytial Virus RSV 66 Osteoporosis Treatment 66 lipid elevations 66 Decompensated Heart Failure 66 Emboli 66 Muscle Function 66 Autoimmune Diseases 66 Blood Thinner 66 Cigarette Smoke 66 Conjugated 66 Double Blind Randomized 66 Impairs 66 Genetic Variant 66 Aneurysm Repair 66 severe oral mucositis 66 hyperphenylalaninemia HPA due 66 Captopril 66 Deep Venous Thrombosis 66 Phase 2b Study 66 Natalizumab 66 Calcification 66 B Cell Lymphoma 66 Erythema 66 Diagnostic Tests 66 Generalized Anxiety Disorder 66 Treatment Naïve 66 Kidney Stones 66 Bosentan 66 Lymphoid 66 Study Showed 66 Critical Limb Ischemia 66 Circulating Tumor Cells 66 induce orthostatic hypotension 66 Prolongs Life 66 Pegylated Liposomal Doxorubicin 66 Mucositis 66 Strongly Linked 66 Treating Heart Failure 66 Hematopoietic 65 Preterm Birth 65 Efficacy Trial 65 Chronic HCV 65 Lowers Blood Pressure 65 Colon Polyps 65 Heartburn Drugs 65 Cytotoxic 65 Myocardial Perfusion Imaging 65 Advanced Renal Cell 65 Exacerbations 65 Bacterial Vaginosis 65 Abnormality 65 Vulvar 65 Vascular Dementia 65 Rheumatoid 65 Mg Uk 65 Demonstrates Significant 65 Helps Predict 65 Lamotrigine 65 Liver Cirrhosis 65 Carotid Endarterectomy 65 Pivotal Clinical Trial 65 Venous thromboembolism 65 Decompensated 65 Renal dysfunction 65 oral antidiabetic medication 65 MRSA Infections 65 Urine Test 65 Antipsychotic 65 Arterial Disease 65 Clinical Trial Results 65 Radiation Induced 65 Long Term Survival 65 Erythropoietic 65 Neovascular Age Related Macular 65 Stroke Risk 65 Adefovir 65 Hepatitis B Vaccine 65 IDDM 65 Refractory Angina 65 Prevent Stroke 65 Predict Response 65 Skin Structure Infections 65 Treatment Naive HIV 65 ORLive Presents 65 Phase IIb Trial 65 Gene Mutation Linked 65 Randomized Phase 65 Estrogen Receptor 65 Premature Aging 65 Calcium Intake 65 Demonstrated Significant 65 Inflammatory Arthritis 65 Diagnosis Treatment 65 Hepatitis C Genotype 65 Pegylated 65 Prostate Cancer Recurrence 65 RNAi Therapeutic 65 Combination REOLYSIN R 65 thromboembolism 65 Newly Diagnosed Breast Cancer 65 Genetic Mutation 65 Paroxysmal 65 Lanthanum Carbonate 65 Safinamide 65 Stress Induced 65 Etiology 65 Fewer Side Effects 65 Preterm Labor 65 Novel Therapeutic 65 Study Demonstrates 65 Subclinical 65 Delayed Graft Function 65 Menopausal Women 65 Inflammatory Disease 65 venous thromboembolic disease 65 Hepatic Encephalopathy 65 Contrast Agent 65 Preterm Infants 65 Elevated Levels 65 Genetic Variation 65 Cardiogenic Shock 65 Bare Metal Stents 65 bullous 65 Telithromycin 65 imipramine Tofranil 65 Prostate Cancer Progression 65 Investigational Agent 65 Differential Diagnosis 65 Tumor Response 65 Brain Metastases 65 Heart Ailments 65 Kidney Transplant Patients 65 Esophagitis 65 Lymphatic System 65 Reduces Pain 65 Genital Warts 65 Lung Cancers 65 Maven Semantic 65 Chronic Insomnia 65 Allergic Reactions 65 Antiplatelet Therapy 65 Autoantibodies 65 Bronchiectasis 65 Lipid Levels 65 Proton Pump Inhibitors 65 Demonstrate Significant 65 piroxicam 65 unfractionated heparin UFH 65 Darapladib 65 Recurrence 65 Myocardial infarction 65 Glioma 65 Ranolazine 65 TNF Tumor Necrosis Factor 65 Relapsed Refractory Multiple Myeloma 65 Dehydrogenase 65 ACE Inhibitor 65 JAK Inhibitor 65 Induces 65 FDA Approves Drug 65 Percutaneous Coronary Intervention 65 Cutaneous T 65 Blood Pressure Drug 65 Prostatitis 65 Premature Babies 65 Invasive Pneumococcal Disease 65 Advanced Colorectal Cancer 65 Cilostazol 65 Clinical Trial Evaluating 65 leukoencephalopathy 65 Valsartan 65 Androgen Independent 65 Colorectal Cancer Patients 65 Partial Onset Seizures 65 Survival Rates 65 Epoetin Alfa 65 Ventricular Arrhythmias 65 Protease Inhibitors 65 Male Infertility 65 Peptide YY 65 recurrent glioblastoma multiforme 65 Bare Metal Stent 65 Investigational Drug 65 Psychiatric Disorders 65 Bone Marrow Transplants 65 Hormone Replacement 65 Protein Involved 65 Lung Cancer Risk 65 Suicidal Behavior 65 Aromatase Inhibitors 65 metastatic neuroendocrine tumors 65 Osteoporosis Drug 65 Treating Prostate Cancer 65 #:#-# [031] 65 Pelvic Inflammatory Disease 65 Chemotherapy induced 65 total cholesterol triglycerides 65 Gastrointestinal Stromal Tumors 65 Panic Disorder 65 Fatty Liver Disease 65 Immunotherapeutic 65 Confirms Efficacy 65 Chronic Inflammation 65 Portal Hypertension 65 SGPT 65 Inflammatory Diseases 65 Immune Mediated 65 Hyperplasia 65 Eculizumab 65 Efficacious 65 Oral Cavity 65 Epidermal Growth Factor Receptor 65 Effective Than 65 Neuroprotection 65 Vaccine Shows Promise 65 Abciximab 65 Stem Cell Treatment 65 Cognitive Deficits 65 Intracranial Aneurysms 65 Fluticasone 65 Fulvestrant 65 Cervical Disease 65 Epilepsy Drugs 65 LDL Cholesterol 65 Pulmonary Embolism PE 65 Therapeutic Potential 65 Antibiotic Resistant 65 Antidepressants Linked 65 Treatment Naive 65 Esophageal 65 Muscle Wasting 65 Cerebrospinal Fluid 65 Mg Usa 65 Multiple Myeloma Patients 64 CYP#A# CYP#D# 64 Commonly prescribed 64 Blood Flow 64 Long Term Outcomes 64 Clinical Efficacy 64 Stenosis 64 Acute Heart Failure 64 Diagnostic Criteria 64 Viral Infection 64 Ovary Removal 64 Brain Aneurysms 64 Celecoxib APC trial 64 Electrical Stimulation 64 Stent Restenosis 64 Intussusception 64 Dilated Cardiomyopathy 64 Heart Attacks 64 Blood Cancers 64 Treated Patients 64 SPRYCEL ® 64 NMIBC 64 Phase III Trial 64 Helicobacter pylori eradication 64 chronic thromboembolic pulmonary 64 Radiofrequency Ablation RFA 64 Relapsed Multiple Myeloma 64 Sevelamer 64 Parathyroid Hormone 64 Reflux Disease 64 paroxetine Paxil 64 Glycemic Control 64 Advanced Solid Tumors 64 Study Casts Doubt 64 transcranial Doppler ultrasound 64 Atomoxetine 64 Bacterial Infections 64 Coronary Artery 64 Contralateral 64 Hospitalized Patients 64 Dose Escalation 64 Prolonged Survival 64 Tacrolimus 64 Could Detect 64 Hormone Receptor 64 Childhood Asthma 64 #:#-# [023] 64 Metabolic Disease 64 Estrogen Therapy 64 moderate hepatic impairment 64 Neurodegenerative 64 Prognostic Factors 64 nonfatal myocardial infarction MI 64 Diffuse Large B 64 Systemic lupus erythematosus 64 Mouse Models 64 Emerging Therapies 64 Randomised Study 64 Ventricular Tachycardia 64 Cocaine Addiction 64 Ultrasonography 64 Eur J 64 Decitabine 64 ductal adenocarcinoma 64 Breast Cancer Survival 64 Drug Candidate 64 Stent Thrombosis 64 Gene Variant 64 Recurrences 64 Childhood Vaccinations 64 Fibrosis 64 Ovarian Cancers 64 intracerebral 64 Liver Metastases 64 Epileptic Seizures 64 FASLODEX 64 Clotting 64 Pemphigus 64 Acute Exacerbations 64 anticoagulant warfarin 64 acarbose 64 Thrombocytopenia 64 Shows Statistically Significant 64 Therapeutic Efficacy 64 Hypoglycemia 64 Bucindolol 64 Respiratory Virus 64 Glucocorticoids 64 II Clinical Trial 64 Antifungals 64 Blood Clot Risk 64 FDA Okays 64 Thrombus 64 Gastric Ulcers 64 Thyroid Cancer 64 heparin induced thrombocytopenia 64 β blockers 64 Lymph Nodes 64 Attenuates 64 Proliferative 64 Cardiovascular Disease Risk 64 Adult Onset 64 Initiates Clinical Trial 64 Renal Function 64 Medication Adherence 64 Cerebril TM 64 Vitamin D Linked 64 Vaccine Protects Against 64 Bicalutamide 64 Asthma COPD 64 Antitumor 64 Phase 2a Clinical Trial 64 H. Pylori 64 Fibromyalgia Pain 64 Low Dose 64 Autoimmune Disorders 64 myocardial infarction ventricular fibrillation 64 Holds Promise 64 Bisphosphonate 64 Breast Tissue 64 Intracranial 64 Asthma Attacks 64 Inhibits 64 hemorrhagic complications 64 Showed Significant 64 Multiethnic Study 64 Hypertensive 64 Peripheral Artery Disease 64 Prenatal Diagnosis 64 Lung Cancer Trial 64 Epithelial Cell 64 Could Prevent 64 Tolerability 64 Angiotensin Converting Enzyme 64 Treatment Regimens 64 Zoledronic Acid 64 Calcium Supplements 64 Placebo Controlled Trial 64 Signaling Pathway 64 HIV HCV coinfected 64 Help Detect 64 Bipolar Mania 64 Hepatocellular Carcinoma HCC 64 Myelodysplastic Syndrome 64 Hepatocellular 64 Solid Tumors 64 Vidaza azacitidine 64 Intravenous immunoglobulin 64 ACER paper 64 Clinically Significant 64 Stress Urinary Incontinence 64 fluvastatin 64 Pharmacokinetics PK 64 Antidepressant Drug 64 Metabolic Endocrinology 64 Nitazoxanide 64 CYT# potent vascular disrupting 64 Adenoviral 64 Respiratory Syncytial Virus 64 Chronic Myelogenous Leukemia 64 Lipid Lowering Treatment 64 Glucose Metabolism 64 CP CPPS 64 Am J Clin 64 LYSTEDA 64 Aortic Valve Replacement 64 Thyroid Disease 64 Atypical Antipsychotic 64 Trandolapril 64 Nucleoside 64 Asthma Treatment 64 candidemia 64 Pioglitazone 64 Immunomodulatory 64 G CSFs 64 Metabolic Disorder 64 Prenatal Exposure 64 Blocked Arteries 64 Salivary 64 Pivotal Trial 64 gastrointestinal stromal tumors GIST 64 symptomatic intracranial 64 C1 Inhibitor